1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Risk Factors for Discontinuation of Treatment for Neovascular Age-Related Macular Degeneration
(
- Contribution to journal › Article
- 2017
-
Mark
RISK FOR LOW VISUAL ACUITY AFTER 1 AND 2 YEARS OF TREATMENT WITH RANIBIZUMAB OR BEVACIZUMAB FOR PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
(
- Contribution to journal › Article
-
Mark
Treatment for neovascular age-related macular degeneration in Sweden : outcomes at seven years in the Swedish Macula Register
(
- Contribution to journal › Article
- 2016
-
Mark
Reduced occurrence of severe visual impairment after introduction of anti-Vascular Endothelial Growth Factor in wet age-related macular degeneration – a population- and register-based study from northern Sweden
(
- Contribution to journal › Article